| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |